Published in Women's Health Weekly, April 24th, 2006
Researchers in Greece conducted a study "to evaluate the activity and toxicity of gemcitabine and vinorelbine in patients with MBC, previously treated with anthracyclines alone or with taxanes. A total of 86 pretreated patients with MBC (median age 62 years) entered the study. Thirty-six patients had been pretreated with anthracyclines and 8 were resistant."
"The combination of gemcitabine (1000 mg/m2) and vinorelbine (25 mg/m2) was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly